Mr. Speaker, the hon. member should know that my department has not yet completed its studies of this hormone. Once these studies are completed, if the health of Canadians is not at risk, I will have no choice but to allow this hormone to be marketed.
In the House of Commons on March 21st, 1994. See this statement in context.